Correlates of cigarette and alternative tobacco product use among young tobacco users experiencing homelessness.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
08 2019
Historique:
received: 16 10 2018
revised: 12 03 2019
accepted: 19 03 2019
pubmed: 29 3 2019
medline: 29 9 2020
entrez: 29 3 2019
Statut: ppublish

Résumé

Most young people experiencing homelessness smoke cigarettes, but little is known about use of alternative tobacco products (ATPs) such as e-cigarettes or other electronic nicotine delivery systems (ENDS) and little cigars/cigarillos (LCCs). This study examines past month use and correlates of cigarettes and ATP among young tobacco users experiencing homelessness. We surveyed a probability sample of N = 469 unaccompanied homeless 13-25 year olds (mean age = 22; 71% male), who reported past month use of any type of tobacco product, from 25 service and street sites in Los Angeles County. Nearly all (90%) participants reported smoking regular cigarettes, and 78% reported using at least one tobacco product other than regular cigarettes. The most commonly used of these other products was natural cigarettes (55%), followed by LCCs (43%), ENDS (34%), cigars (31%), hookah (14%), chewing tobacco (7%), and snus (5%). Multivariable models indicated that correlates of past month use differed by product, but included sociodemographic characteristics, homelessness severity, depression, exposure to other people who used the product, and product perceptions (e.g., relative access, cost, and harm compared to cigarettes). Use of cigarettes and ATPs are both widespread among young homeless tobacco users, suggesting that efforts to reduce tobacco use in this population should have a broad focus that includes a variety of products. The effectiveness of these efforts may be enhanced by addressing their considerable exposure to other tobacco users, as well as their perceptions of certain products as being less harmful or more cost-effective options than regular cigarettes.

Identifiants

pubmed: 30921625
pii: S0306-4603(18)31209-7
doi: 10.1016/j.addbeh.2019.03.012
pmc: PMC6545131
mid: NIHMS1525408
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

145-151

Subventions

Organisme : NCI NIH HHS
ID : R01 CA204004
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Annu Rev Public Health. 2018 Apr 1;39:215-235
pubmed: 29323609
Addict Behav. 2005 Jul;30(6):1100-10
pubmed: 15925120
Science. 2012 Jul 6;337(6090):49-53
pubmed: 22767921
Drug Alcohol Depend. 2010 Nov 1;112(1-2):140-9
pubmed: 20656423
Drug Alcohol Depend. 2016 Feb 1;159:80-5
pubmed: 26708706
JAMA. 2000 Aug 9;284(6):735-40
pubmed: 10927783
Tob Control. 2017 Dec;26(e2):e85-e91
pubmed: 28003324
Nicotine Tob Res. 2015 Jul;17(7):847-54
pubmed: 25481917
Addict Behav. 2017 Aug;71:38-45
pubmed: 28259026
Prev Med. 2017 Jan;94:65-71
pubmed: 27773711
PLoS One. 2015 Oct 08;10(10):e0139518
pubmed: 26447792
Am J Public Health. 2013 Oct;103(10):1837-44
pubmed: 23948019
Behav Med. 2015;41(3):90-7
pubmed: 26332926
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Am J Orthopsychiatry. 2012 Oct;82(4):482-93
pubmed: 23039346
Prev Med. 2017 Nov;104:71-78
pubmed: 28579496
MMWR Morb Mortal Wkly Rep. 2017 Jun 16;66(23):597-603
pubmed: 28617771
Nicotine Tob Res. 2007 Sep;9(9):977-82
pubmed: 17763115
Am J Prev Med. 2014 Feb;46(2):175-8
pubmed: 24439352
Nicotine Tob Res. 2014 Nov;16(11):1522-6
pubmed: 25145375
JAMA. 2000 Nov 22-29;284(20):2606-10
pubmed: 11086367
Drug Alcohol Depend. 2015 Sep 1;154:105-10
pubmed: 26160458
Toxicol Lett. 2012 Nov 23;215(1):70-5
pubmed: 23059956
Lancet. 2006 Aug 19;368(9536):647-58
pubmed: 16920470
Tob Regul Sci. 2019 Jan;5(1):65-75
pubmed: 31289730
Am J Addict. 2006;15 Suppl 1:80-91
pubmed: 17182423
Am J Health Behav. 2010 May-Jun;34(3):275-85
pubmed: 20001185
J Stud Alcohol. 2003 Jan;64(1):5-14
pubmed: 12608478

Auteurs

Joan S Tucker (JS)

RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA 90407-2138, United States of America. Electronic address: jtucker@rand.org.

William G Shadel (WG)

RAND Corporation, 4570 Fifth Avenue, Suite 600, Pittsburgh, PA 15213-2665, United States of America.

Daniela Golinelli (D)

RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA 90407-2138, United States of America.

Rachana Seelam (R)

RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA 90407-2138, United States of America.

Daniel Siconolfi (D)

RAND Corporation, 4570 Fifth Avenue, Suite 600, Pittsburgh, PA 15213-2665, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH